摘要
背景:5-氟尿嘧啶类药物存在毒性大、体内代谢时间短等临床问题。目的:制备海藻酸钠/层状双氢氧化物-5-氟尿嘧啶凝胶珠载药体系,考察其载药量、微观形貌、体外释放及对肝癌细胞的抑制效果。方法:设置层状双氢氧化物-5-氟尿嘧啶溶胶液与海藻酸钠溶液的体积比分别为3∶5,4∶5,5∶5,采用离子凝胶法制备海藻酸钠/层状双氢氧化物-5-氟尿嘧啶凝胶珠,检测其载药量。将海藻酸钠/层状双氢氧化物-5-氟尿嘧啶凝胶珠分别放置于pH=2.1,4.6,7.4的PBS中,定时检测5-氟尿嘧啶释放率。将肝癌SMMC-7 721细胞株分组培养,分别加入不同质量浓度(5,10,20,40 mg/L)的海藻酸钠、层状双氢氧/5-氟尿嘧啶凝胶珠、海藻酸钠/层状双氢氧化物-5-氟尿嘧啶凝胶珠混悬液,培养24 h后,检测细胞抑制率。结果与结论:(1)体积比3∶5,4∶5,5∶5载药体系的载药量分别为(3.09±0.08)%,(4.55±0.10)%,(5.47±0.14)%;(2)与pH=7.4条件比较,海藻酸钠/层状双氢氧化物-5-氟尿嘧啶凝胶珠在pH=2.1,4.6条件下释放5-氟尿嘧啶速度较快,并且随着5-氟尿嘧啶负载量的增加,5-氟尿嘧啶的释放速度逐渐增加;(3)不同质量浓度海藻酸钠对肝癌SMMC-7 721细胞株的抑制作用较小;随着质量浓度的增加,层状双氢氧/5-氟尿嘧啶凝胶珠、海藻酸钠/层状双氢氧化物-5-氟尿嘧啶凝胶珠对肝癌SMMC-7721细胞株的抑制作用逐渐增强,且海藻酸钠/层状双氢氧化物-5-氟尿嘧啶凝胶珠的抑制作用更强;(4)结果表明,海藻酸钠/层状双氢氧化物-5-氟尿嘧啶凝胶珠具备pH选择性缓释作用及较强的肿瘤抑制效果。
BACKGROUND: In clinical practice, 5-fluorouracil (5-Fu) has disadvantages such as high toxicity and short metabolism time. OBJECTIVE: To prepare the sodium alginate (SA)/layered double hydroxides (LDH)-5-Fu delivery system and to explore its drug loading, micromorphology, in vitro release and inhibitory effect on hepatoma cells. METHODS: LDH-5-Fu solution and SA solution were mixed at a ratio of 3:5, 4:5 and 5:5 to prepare SA/LDH-5-Fu beads using ionic gel method, respectively. The drug loading capacity of these beads was then tested. SA/LDH-5-Fu beads were placed in PBS of pH=2.1, 4.6, and 7.4, and the release rate of 5-Fu was measured periodically. SMMC-7 721 hepatoma cells were cultured with the SA at different concentrations (5, 10, 20, 40 mg/L), LDH-5-Fu beads, and SA/LDH-5-Fu bead suspension for 24 hours, and then the cell inhibitory rate was detected. RESULTS AND CONCLUSION: The drug loading rate of SA/LDH-5-Fu at 3:5, 4:5, and 5:5 was (3.09±0.08)%, (4.55±0.10)%, and (5.47±0.14)%, respectively. The release of 5-Fu from the SA/LDH-5-Fu beads at pH=2.1 and 4.6 was faster than that at pH=7.4. Moreover, the release of 5-Fu was gradually fastened with the increasing input amount of 5-Fu. SA showed little inhibition effect on SMMC-7721 cells, while the inhibitory rate of LDH-5-Fu or SA/LDH-5-Fu to SMMC-7721 in vitro was gradually increased, and the inhibitory rate of SA/LDH-5-Fu was significantly higher than that of LDH-5-Fu. These findings reveal that SA/LDH-5-Fu is a potential pH sensitive anti-tumor drug release system.
作者
韩晓静
杨红
孙笑宇
王辉
王庆峰
Han Xiao-jing;Yang Hong;Sun Xiao-yu;Wang Hui;Wang Qing-feng(Department of Pharmaceutical Engineering,Shanxi Pharmaceutical Vocational College,Taiyuan 030031,Shanxi Province,China;Department of Chemical Industry and Environment,Liaoning Shihua University,Fushun 113001,Liaoning Province,China;College of Food Science and Technology,Shenyang Normal University,Shenyang 110032,Liaoning Province,China)
出处
《中国组织工程研究》
CAS
北大核心
2018年第26期4168-4173,共6页
Chinese Journal of Tissue Engineering Research
基金
沈阳市科技计划项目(18-013-0-44)~~